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Acinetobacter baumannii is a multidrug-resistant pathogen associated with hospital outbreaks of infection across the globe, par-
ticularly in the intensive care unit. The ability of A. baumannii to survive in the hospital environment for long periods is linked
to antibiotic resistance and its capacity to form biofilms. Here we studied the prevalence, expression, and function of the A. bau-
mannii biofilm-associated protein (Bap) in 24 carbapenem-resistant A. baumannii ST92 strains isolated from a single institu-
tion over a 10-year period. The bap gene was highly prevalent, with 22/24 strains being positive for bap by PCR. Partial sequenc-
ing of bapwas performed on the index case strainMS1968 and revealed it to be a large and highly repetitive gene approximately
16 kb in size. Phylogenetic analysis employing a 1,948-amino-acid region corresponding to the C terminus of Bap showed that
BapMS1968 clusters with Bap sequences from clonal complex 2 (CC2) strains ACICU, TCDC-AB0715, and 1656-2 and is distinct
from Bap in CC1 strains. By using overlapping PCR, the bapMS1968 gene was cloned, and its expression in a recombinant Esche-
richia coli strain resulted in increased biofilm formation. A Bap-specific antibody was generated, andWestern blot analysis
showed that the majority of A. baumannii strains expressed an200-kDa Bap protein. Further analysis of three Bap-positive A.
baumannii strains demonstrated that Bap is expressed at the cell surface and is associated with biofilm formation. Finally, bio-
film formation by these Bap-positive strains could be inhibited by affinity-purified Bap antibodies, demonstrating the direct
contribution of Bap to biofilm growth by A. baumannii clinical isolates.
Acinetobacter baumannii is a Gram-negative bacterial pathogenassociated with multidrug resistance and hospital outbreaks
of infection, particularly in the intensive care unit (1).A. bauman-
nii accounts for almost 80% of all reported Acinetobacter infec-
tions, including ventilator-associated pneumonia, bacteremia,
meningitis, peritonitis, urinary tract infections, and wound infec-
tions (2, 3). The rapid emergence of multidrug-resistant A. bau-
mannii strains has resulted in limited treatment options, with
most strains being resistant to clinically useful antibiotics, such as
aminoglycosides, fluoroquinolones, -lactams (including car-
bapenems), tetracyclines, and trimethoprim-sulfamethoxazole
(4, 5).
In addition to antibiotic resistance, the ability to form biofilms
represents an important factor associated with A. baumannii viru-
lence. Biofilms are sessile bacterial communities enclosed in amatrix
comprised of extracellular material that can include polysaccharide,
protein, and DNA (6). Biofilm formation by bacterial pathogens is
associated with enhanced tolerance to host immune defenses, disin-
fectants, and antimicrobials (7, 8).A. baumannii strains readily form
biofilms in vitro, and some of the molecular mechanisms associated
with this phenotype have been studied; genes associatedwith biofilm
formation include the csu locus (encoding the chaperone-usher Csu
fimbriae), the pga locus (encoding the polysaccharide poly-N-acetyl-
glucosamine [PNAG]), ompA (encoding the outer membrane pro-
tein OmpA), and bap (encoding the biofilm-associated protein
[Bap]) (9–15).
A. baumannii Bap (BapAb) is a cell surface protein associated
with biofilm formation. In the A. baumannii bloodstream isolate
307-0294, BapAb307-0294 is a large (854-kDa) protein comprised of
multiple copies of repeat elements (13). Mutation of bap in A.
baumannii 307-0294 resulted in decreased biofilm growth and
decreased adherence to human bronchial epithelial and neonatal
keratinocyte cells (13, 16). Bap homologues have also been iden-
tified and characterized in other bacteria, including members of
other genera typically associated with hospital-acquired infection,
such as Staphylococcus (17), Enterococcus (18, 19), and Pseudomo-
nas (20, 21). Staphylococcus aureusBap (BapSa) has beenwell char-
acterized and is an important virulence factor that contributes to
initial attachment, intercellular adhesion, and biofilmmaturation
(17, 22). Bap proteins from other organisms contribute to differ-
ent stages of biofilm formation and adhesion to eukaryotic host
cells (17, 22).
We previously assessed the molecular epidemiology of A. bau-
mannii within a single, large institution and showed that A. bau-
mannii strains from sequence type 92 (ST92) were dominant over
a 10-year period (5). In this study, we examined the role of Bap in
these A. baumannii ST92 strains. We show that almost all A. bau-
mannii ST92 strains express Bap and that its expression is strongly
associated with biofilm formation. This is the first analysis of Bap
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function in A. baumannii ST92 strains associated with hospital
infection outbreaks.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Twenty-four car-
bapenem-resistant ST92 clinical isolates were selected from a collection of
A. baumannii (isolated between 1999 and 2009) that caused sporadic and
outbreak cases at the Royal Brisbane and Women’s Hospital, Brisbane,
Australia (Table 1), some of which have been described previously (5).
The Escherichia coli strains MS2989 (DH10 containing plasmid pSG25;
bapMS1968 in pBR322) andMS3640 (DH10 containing the vector control
plasmid pBR322)were used.A. baumannii strainswere routinely grown at
28°C in tryptic soy broth (TSB; Becton, Dickinson) supplemented with
ampicillin (100 g/ml) or kanamycin (50 g/ml) as required. E. coli
strains were cultivated in Luria-Bertani (LB) medium supplemented with
ampicillin (100 g/ml) as required.
DNA manipulations and genetic techniques. Chromosomal DNA
was extracted fromA. baumannii strains by previously describedmethods
(23). PCR was performed using either Taq polymerase (New England
BioLabs) or an Expand long-template PCR system (Roche) according to
the manufacturer’s instructions. PCR products were purified using a
QIAquick PCR purification kit or a QIAquick gel extraction kit with spin
columns according to themanufacturer’s instructions (Qiagen). Standard
cloning techniques were employed to construct recombinant plasmids
(24); plasmid DNA was isolated using a QIAprep spin miniprep or mid-
iprep kit (Qiagen). DNA sequencing reactions were carried out with an
ABI BigDye terminator sequencing kit (version 3.1) (Applied Biosys-
tems).
PCR screening of the bap gene. The 24 ST92 A. baumannii clinical
isolates were screened for the presence of the bap gene by using primers
1415F (5=-TACTTCCAATCCAATGCTAGGGAGGGTACCAATGCAG)
and 1416R (5=-TTATCCACTTCCAATGATCAGCAACCAAACCGCT
AC). This gene region corresponded to the region selected for anti-Bap
serum production.
Size determination and cloning of the bap gene. In order to ascertain
the exact size of the MS1968 bap gene, a long-range PCR was performed
using Expand long-template PCR system 1 (primers 1649F [5=-CTAGCC
AACCATGCATGATCCAAAT] and 1652R [5=-GCGCGGGATCCGCAT
GAACTCTTTCAAAGCTAGG]). Amplification products were then re-
solved on a low-percentage-agarose gel using the lambda DNA/HindIII
marker (Fermentas) as a reference, and the product size was estimated
using Bio-Rad Image Lab software (Bio-Rad). For cloning bap into
pBR322, the bap gene of MS1968 was amplified in two sections: the 5=
fragment (primers 1649F and 1650R [GCGCGGGATCCTTTAAAGGT
TGCGGTTCCAG]) and the 3= fragment (1651F [5=-CTTGGTAGGCGG
AGCAGTAG] and 1652R. The 5= fragment was digested with BmtI/
BamHI and ligated into the BmtI/BamHI sites of pBR322 to generate
plasmid pSG24. Screening primers 1415F and 1416R were used to verify
the presence of the 5= bap fragment on pSG24, and primers 831F (5=-GC
GCTCATCGTCATCCTC) and 1161R (5=-CCCTTATGCGACTCCT
GC), which target the plasmid at the junction sites, were used to verify the
cojoining plasmid-insert region by sequencing. The 3= fragment was di-
gested with BsrGI/BamHI and ligated into the BsrGI/BamHI sites of
pSG24 to generate pSG25. This plasmid was verified by sequencing the 5=
and 3= joining sites. The confirmed clone (MS2989) was then tested for
Bap expression and biofilm formation.
DNA sequencing, assembly and bioinformatics.The sequence of the
bapMS1968 gene in pSG25 was determined by primer walking and Sanger
sequencing, and sequence reads were manually assembled using Vector
NTIAdvance software (Life Technologies). The assembledDNA sequence
of bapMS1968 was compared against bapAB307-0294 using Easyfig (25). The
C-terminal sequence of BapMS1968 (1,948 amino acids) was determined
using the BLASTp program (NCBI) and aligned with Bap homologues
obtained from the NCBI database using Vector NTI Advance and Clust-
alW2 (26). The alignment generated using Vector NTI Advance was used
to determine the region within Bap homologues that corresponded with
the C-terminal sequence of BapMS1968. A neighbor-joining tree was gen-
erated using MEGA5 (27) by comparing 1,948 amino acids from the C-
terminal sequence of BapMS1968 against amino acid sequences of Bap ho-
mologues identified in the NCBI database.
Generation of Bap polyclonal antiserum, affinity purification, and
immunoblotting. A polyclonal antibody against BapMS1968 was prepared
by amplifying a 1,254-bp segment of the bapMS1968 gene using primers
1415F and 1416R with ligation-independent cloning (LIC) overhangs
flanking both ends of the primers to enable cloning into the pMCSG7
6-histidine N-terminally tagged expression vector (28). The resultant
plasmid (pSG13) contained base pairs 132 to 1,386 of bapMS1968 fused to
anN-terminal 6His-encoding sequence. This bap sequence corresponds
to amino acid residues 45 to 462 (418 amino acids) of the BapMS1968
sequence. E. coli BL21 was transformed with plasmid pSG13, and the
desired clones were confirmed by PCR and sequencing using primers
1508F (5=-TAATACGACTCACTATAGGG) and 1509R (5=-TATGCTAG
TTATTGCTCAG).MS2788 (BL21pSG13) was induced with 1mM iso-
propyl -D-1-thiogalactopyranoside (IPTG), and the resultant fusion
protein was purified using a Qiagen nickel-nitrilotriacetic acid (Ni-NTA)
spin kit according to the manufacturer’s instructions. Protein was as-
sessed for purity by SDS-PAGE analysis and quantified using a bicin-
choninic acid kit (Sigma-Aldrich) (29). A polyclonal anti-Bap serum was
raised in rabbits at the Institute of Medical and Veterinary Sciences (Ad-
elaide, South Australia, Australia).
Affinity chromatography was used to purify Bap-specific antibodies
from the rabbit polyclonal anti-Bap serum as follows. A 30-ml culture of
MS2788 was grown at 37°C to an optical density at 600 nm (OD600) of 0.6
in the presence of 1 mM IPTG. Cells were pelleted via centrifugation and
resuspended in chilled sonication buffer (25mMTris, 150mMNaCl [pH
7.0]). The suspension was sonicated three times with a 30-s burst and a
2-min incubation on ice between bursts. The cell extract was centrifuged
TABLE 1 Prevalence and expression of bap in A. baumannii ST92
clinical isolates
Isolate
bap
genea
Bap
expressionb
Yr of
isolation
Previous
designationc
MS1962   2004 Q11
MS1966   2001 Q5
MS1968   2001 Q6
MS1970   2001 Q7
MS1972   2000
MS1976   2000
MS1978   2000
MS1980   2004 Q10
MS1984   2006 Q15
MS2992   2005 Q12
MS2993   2006 Q13
MS2995   2006 Q16
MS2996   2006 Q17
MS2998   2006 Q19
MS3000   2006 Q21
MS3002   2007
MS3003   2007
MS3004   2008 Q25
MS3005   2008 Q26
MS3007   2008 Q28
MS3009   2008
MS3010   2008
MS3011   2009
MS3014   2009
a Determined by PCR.
b Determined by Western blot analysis.
c Strain designation reported in reference 5.
Goh et al.
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at 12,000  g for 20 min at 4°C. The column was prepared using a 1-ml
bed volume of Talon cobalt metal affinity resin (Clontech) and equili-
brated using 5ml of equilibration/wash buffer (25mMTris, 10mMNaCl
[pH 7.0]). The MS2788 cell lysate was applied to the column, and non-
specific proteins were removed using 20 ml of equilibration/wash buffer.
An aliquot of the polyclonal Bap antiserum was diluted with an equal
volume of Tris-buffered saline (TBS) buffer (pH 7.2 to 7.4) and applied to
the affinity column. Nonspecific proteins were removed using equilibra-
tion/wash buffer. Bap-specific antibodies bound on the column were
eluted using a gentle antigen-antibody (Ag/Ab) elution buffer, pH 6.6
(Pierce). A 30-kDa desalting column (Millipore) was used to concentrate
and exchange the purified antibodies into TBS buffer. Flowthrough frac-
tions were collected at every step of purification for SDS-PAGE and im-
munoblotting analysis. Immunoblotting was performed as previously de-
scribed (29). A 1:200 dilution of affinity-purified Bap-specific antibodies
was used as primary serum, and the secondary antibody was alkaline
phosphatase-conjugated anti-rabbit IgG (Sigma-Aldrich).
Extracellular matrix (ECM) protein binding assays. ECM protein
binding by A. baumannii to MaxGel human ECM (Sigma-Aldrich) was
performed as described previously, with the exception that wells were
washed with phosphate-buffered saline (PBS) and quenched with 2% bo-
vine serum albumin (BSA) in PBS for 1 h, and overnight bacterial cultures
were standardized to anOD600 of 1.0 (30). For negative-control wells, PBS
was added instead of bacteria. Instead of an enzyme-linked immunosor-
bent assay (ELISA), adherent cells were stained with 0.01% crystal violet
for 30 min at room temperature. Wells were washed twice with PBS and
incubated with 200 l ethanol/acetone (80:20) for 1 h at room tempera-
ture with gentle agitation. Absorbance measurements were obtained at
595 nm, and results were analyzed by analysis of variance (ANOVA)
(GraphPad Prism 5 software).
Biofilm study. Biofilm formation by A. baumannii on 96-well poly-
styrene plates (Iwaki) was performed by previously described protocols,
except that strainswere grown at 28°C inTSBunder static conditions (31).
Biofilm formation by DH10 was performed as described above, except
that cells were grown with shaking in polyvinylchloride (PVC) microtiter
plates containing M9 supplemented with 0.3% Casamino Acids. Briefly,
strains were grown as shaking cultures at 250 rpm for 20 h at 28°C in the
appropriate culture medium supplemented with antibiotics, inoculated
into microtiter plates with fresh medium, and incubated for 24 h at 28°C;
wells werewashed to remove unbound cells and subsequently stainedwith
0.01% crystal violet. Bound cells were quantified by addition of ethanol-
acetone (80:20) and measurement of the solubilized stain at an optical
density of 595 nm using a Spectramax 250 microtiter plate reader with
SOFTmax Pro v2.2.1 software (Molecular Devices). Readings obtained
were analyzed by ANOVA (GraphPad Prism 5 software). These experi-
ments were performed in eight replicates. Inhibition of biofilm formation
using Bap affinity-purified antibody was performed using the microtiter
plate biofilm protocol mentioned for A. baumannii, except that Bap-spe-
cific antibodieswere added to a final concentration of 1:10 before addition
of bacteria to the polystyrene plate. Readings obtained were analyzed by
ANOVA. This experiment was performed in quadruplicate. Flow cham-
ber biofilm experiments were performed as previously described (32),
except that cells were grown in TSB supplemented with ampicillin and
detected using 0.1 M BacLight green fluorescent stain (Molecular
Probes). Briefly, biofilms were allowed to form on glass surfaces in a mul-
tichannel flow system that permitted online monitoring of community
structures. Flow cells were inoculated with standardized overnight cul-
tures grown in TSB. Biofilm development was monitored by confocal
laser scanning microscopy (CLSM) from 19 to 48 h postinoculation. This
experiment was performed in duplicate.
Microscopy and image analysis. An anti-Bap serum was used for
immunofluorescence microscopy as previously described (33), with
modifications where strains were grown in TSB and a 1:5 dilution of
the primary antibody was used followed by goat anti-rabbit IgG anti-
body conjugated to fluorescein isothiocyanate (FITC) (1:500) as the
secondary antibody. Microscopic observation of biofilms and image
acquisition was performed on a confocal laser scanning microscope
(LSM510 Meta; Zeiss). Vertical cross sections through the biofilms
were visualized using the Zeiss LSM image examiner, and the z stacks
were analyzed using COMSTAT software (34). Results were analyzed
by ANOVA (Minitab Statistical Software). Images were further pro-
cessed for display by using Photoshop software (Adobe Systems).
Protein sequence accession number. The sequence of BapMS1968 has
been submitted to the GenBank database under accession numbers
AGM37925.
RESULTS
The bap gene is highly prevalent in A. baumannii ST92 strains.
Twenty-four carbapenem-resistant A. baumannii ST92 strains
isolated from a single institution during a 10-year period from
1999 to 2009 were examined for the presence of the bap gene.
Initially, a draft genome sequence of one strain, MS1968, was de-
termined, and this provided a partial sequence for bap, albeit with
gaps in the large repeat regions. Based on this sequence, primers
1415F and 1416R were designed to amplify a 1,225-bp segment of
bapMS1968 from a nonrepetitive region. PCR analysis was per-
formed on all 24 A. baumannii ST92 strains, and a product of the
correct size was detected in 91.7% (22/24) of the strains, demon-
strating that the bap gene is highly prevalent in our collection
(Table 1).
Cloning of the bap gene from A. baumanniiMS1968. Based
on the draft genome sequence of A. baumannii MS1968 and pre-
liminary PCR assays, the size of bapMS1968 was estimated to be
approximately 16 kb (data not shown). In order to clone
bapMS1968, two overlapping PCR amplicons were generated (a
12,144-bp fragment containing the 5= region and a 4,170-bp frag-
ment containing the 3= region). These fragments were cloned into
plasmid pBR322 in a two-step process to generate plasmid pSG25,
which contained the full-length bapMS1968 gene.
Sequencing of bapMS1968 and comparative analysis with
other bap genes. In order to close the gap within the bapMS1968
gene from the draft genome sequence, the sequence of bapMS1968
was determined from plasmid pSG25 using a primer walking
strategy. Approximately 9.5 kb of bapMS1968, including 3,783 bp of
the 5= region and 5,847 bp of the 3= region, was sequenced, leaving
an estimated 5,500-bp gap that could not be closed by thismethod
(Fig. 1). A nucleotide sequence alignment using ClustalW2 indi-
cated that bapMS1968 and bapAB307-0294 share approximately 50%
sequence identity (Fig. 1). The5,500-bp unsequenced region of
bapMS1968 ismost likelymade up of the core repeatmoduleD, thus
causing the eventual sequencing problems.
Analysis of the 5,847-bp segment corresponding to the 3= region
of bapMS1968 revealed an in-frame translated sequence comprising
1,948 amino acids. An amino acid sequence alignment using Clust-
alW2 indicated that this region of BapMS1968 shares 37% sequence
identity with the corresponding region of BapAB307-0294 (residues
6,669 to 8,620). The amino acid sequence similarity of BapMS1968
with other Bap proteins was evaluated using MEGA5 (27). Figure
2 illustrates a neighbor-joining tree constructed using aligned Bap
amino acid sequences from 26 bacterial strains. A consensus tree
of 1,000 bootstrap replicates revealed two major clades. The two
clades separate themajority of the Gram-negative and Gram-pos-
itive Bap proteins (with the exception of Bordetella bronchiseptica,
Pseudomonas fluorescens, andPseudomonas putida). The predicted
Bap protein homologues of A. baumannii cluster within the large
clade of the Gram-negative Bap homologues. A scheme for classi-
Bioﬁlm-Associated Protein of A. baumannii
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fying A. baumannii into clonal complexes (CC) was proposed by
Diancourt et al. in 2010 and reported AB307-0294, AB0057, and
AYE as representatives of CC1, whereas European clone II isolates
ACICU, TCDC-AB0715, and 1656-2 represented CC2 (35–37).
Consistent with this scheme, BapMS1968 clustered together with
Bap from other CC2 strains. The separate clustering of CC1 and
CC2 Bap proteins indicates the presence of Bap variants within A.
baumannii.
We also examined the genetic context of bap in A. baumannii.
Based on the draft genome sequence of MS1968, the chromo-
somal location of bap1968 is identical to that previously described
for A. baumannii 307-0294 (38). The bap gene appears to be dis-
rupted in many complete A. baumannii genome sequences avail-
able in public databases, a consequence of its intrinsic repetitive
features that might be an obstacle for the correct assembly of its
coding region. We selected the complete genome sequences of
Acinetobacter species in which bap appeared to be correctly assem-
bled and compared the corresponding genomic regions (Fig. 3A).
Bap fromAB307-0294 is 94.7% identical at the amino acid level to
Bap from AYE and BJAB0715; however, this is reduced signifi-
cantly compared to Bap from PHEA-2 (67.9% amino acid iden-
tity), Bap from ADP1 (28.5% amino acid identity), and Bap from
SDF (27.6% amino acid identity). Despite these differences, bap is
located at the same genome position in all six strains, flanked by a
core and a variable region. The core upstream region is repre-
sented by genes encoding succinyl coenzyme synthetase (sucCD),
a tricarboxylic cycle enzyme that catalyzes the interconversion of
succinyl coenzyme A (succinyl-CoA) and succinate, accompanied
by the production or hydrolysis of GTP (39). The core down-
stream region contains genes encoding carbamoylphosphate syn-
thetase (carAB), an intermediate in the biosynthesis of arginine
and pyrimidines (40), and greA, a transcriptional elongation fac-
tor with chaperone activity that inhibits aggregation of proteins
under heat shock conditions and promotes the refolding of dena-
tured proteins (41). The variable flanking region of bap was not
conserved in the Acinetobacter genomes analyzed and contained
genes encoding hypothetical proteins, a gene encoding a putative
Na/H antiporter (ABBFA_000774), and genes encoding puta-
tive metalloproteases (ABBFA_000773 and ABBFA_000781). Fi-
nally, analysis of the intergenic regions up- and downstream of
bap revealed the presence of palindromic repeats (Fig. 3B), sug-
gesting that the variable regions may have been acquired through
independent recombination events.
Expression of Bap by E. coli harboring pSG25 results in in-
creased biofilm formation. To demonstrate functional expres-
sion of Bap from plasmid pSG25 in E. coli, a polyclonal antibody
was generated against a conserved, nonrepetitive region within
BapMS1968. SDS-PAGE and Western blot analysis of whole-cell
lysates ofMS2989 (E. coliDH10 containing pSG25) grown in LB
broth identified an200-kDa protein that reacted with the Bap-
specific antiserum (data not shown). A microtiter plate biofilm
assay demonstrated that expression of the bap gene by DH10
resulted in significantly increased biofilm formation by MS2989
compared to the vector control strain (MS3640) (Fig. 4). Thus,
Bap can be expressed by E. coli, and its expression leads to in-
creased biofilm formation.
Bap is expressed by most A. baumannii ST92 isolates. To
investigate the expression of Bap in our collection of 24 A. bau-
mannii ST92 strains, whole-cell lysates were prepared from each
strain following overnight shaking growth in TSB and examined
byWestern blot analysis using theBap-specific antibody described
above. A strong Bap-specific cross-reacting band was detected at
200 kDa in all but one of the 24 strains tested (95.8%; Table 1).
This analysis identified inconsistencies with respect to the PCR
prevalence assay; strains MS1976 and MS3003 expressed Bap but
were negative in the PCR screen for the bap gene, while MS3007
failed to express Bap butwas positive in the PCR screen.Out of the
24 ST92 strains, four strains were selected for further analysis of
Bap expression and function, three strains positive for Bap expres-
sion (MS3009, MS3011 and MS3014) and one strain negative for
Bap expression (MS3007) (Fig. 5A).
Bap is located at the cell surface. The cellular localization of
FIG 1 Physical representation of the nucleotide sequence alignment between bapMS1968 (GenBank accession no. KC981110) and bapAB307-0294 (EU117203) (13).
The size of bapMS1968 was determined by PCR (16 kb), and the sequence was obtained by primer walking. The black bar indicates the region (5,500 bp) that
could not be sequenced using primer walking. The yellow arrow indicates the region (1,254 bp) cloned and expressed for antibody production. Themagenta bar
indicates the region (5,847 bp) selected for phylogenetic analysis (Fig. 3). This figurewas generated using Easyfig (http://easyfig.sourceforge.net/) with nucleotide
sequence comparison (BLASTn) (25). The level of nucleotide identity is shown in the gradient scale.
Goh et al.
6538 aem.asm.org Applied and Environmental Microbiology
 o
n
 N
ovem
ber 11, 2015 by University of Queensland Library
http://aem
.asm
.org/
D
ow
nloaded from
 
Bap in A. baumannii ST92 strains was investigated by immuno-
fluorescence microscopy employing our affinity-purified Bap an-
tibody. Consistent with the Western blot analysis (Fig. 5A), the
Bap antiserum reacted with MS3009, MS3011, and MS3014. In
contrast, no reaction was observed for MS3007 (Fig. 5B). Thus,
Bap is effectively expressed and is localized on the cell surfaces of
A. baumannii strains MS3009, MS3011, and MS3014.
BapAb does notmediate binding to ECMmolecules.The four
strains selected for Bap characterization (MS3007, MS3009,
MS3011, and MS3014) were tested for their ability to bind
MaxGel, a commercially available mixture of human ECM com-
ponents, including collagens, laminin, fibronectin, tenascin, elas-
tin, and a number of proteoglycans and glycosaminoglycans.
None of the strains displayed significant binding toMaxGel in this
assay (data not shown), suggesting that Bap expression by
MS3009, MS3011, and MS3014 does not lead to adherence to
ECM components under the conditions used in this experiment.
Expression of Bap is associated with strong biofilm forma-
tion. Biofilm formation by A. baumannii was examined using dy-
namic and static biofilm assays. The continuous flow chamber
method was used to test the ability of Bap to promote biofilm
formation under dynamic conditions, which permits monitor-
ing of the bacterial distribution within an evolving biofilm at
the single-cell level using scanning confocal laser microscopy.
In this assay, the Bap-positive strains MS3009, MS3011, and
MS3014 formed a dense, mat-like biofilm across the glass sur-
face with significantly higher substratum coverage (53.26%,
60.7%, and 60.38%, respectively) than the Bap-negative strain
MS3007 (29.96%; P  0.002) (Fig. 6). In the static microtiter
plate assay, the Bap-positive strains MS3009, MS3011, and
MS3014 produced a strong biofilm compared to the Bap-neg-
ative strain MS3007 (P  0.0001) (Fig. 7). Taken together,
these results demonstrate that the Bap-expressing A. bauman-
nii strains MS3009, MS3011, and MS3014 can form strong bio-
FIG2 Neighbor-joining tree indicating sequence similarity of BapMS1968 (GenBank accession no. AGM37925) in relation to Bap homologues fromA. baumannii
strains (TCDC-AB0715 [accession number ADX93581]; ACICU [ACC58250, ACC58252 to ACC58258]; 1656-2 [ADX04628 to ADX04634]; ATCC 19606
[EEX02997]; ATCC 17978 [ABO13109]; AB307-0294 [ABX00640]; AYE [CAM85746]; AB0057 [ACJ41698]), Acinetobacter baylyi (CAG69594), Burkholderia
cepacia (AAT36485), Salmonella enterica serovar Enteritidis (ABX46037), Salmonella enterica serovar Typhi (NP_806354), Vibrio parahaemolyticus
(NP_800463), Escherichia coli (ACB16711), Listeria monocytogenes (CAC98514), Staphylococcus aureus (AAK38834), Staphylococcus epidermidis (AAY28519 and
AAK29746 [Bhp]), Bordetella bronchiseptica (AAG53941), Pseudomonas fluorescens (AAY95545), Pseudomonas putida (NP_742337), Enterococcus faecalis
(AAD09858), Enterococcus faecium (EFF33494), Lactobacillus reuteri (EDX43426), and Streptococcus pyogenes (AAD39085). Sequences were aligned using
ClustalW2, and the phylogenetic tree was generated in MEGA5 by comparing 1,948 amino acids from the C-terminal sequence of BapMS1968. Numbers at the
branches indicate confidence values determined from 1,000 bootstrap replications. The A. baumannii Bap proteins cluster according to their CC designations; a
CC has not been proposed for the ATCC strains. The red arrow indicates themost recent common ancestor shared by CC1 andCC2 Bap proteins. The twomajor
clades demonstrate separate clustering of Gram-negative andGram-positive Bap homologues (with the exception of L. monocytogenes andV. parahaemolyticus).
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films, while MS3007, which does not express Bap, does not
form a significant biofilm.
Bap is required for biofilm formation in vitro. To further
characterize the role of Bap in biofilm formation by A. baumannii
MS3009, MS3011, and MS3014, we performed microtiter plate
biofilm assays in the presence of affinity-purified Bap-specific an-
tibody. In these assays, the addition of 1:10-diluted Bap antibody
inhibited biofilm formation by all three strains (P 0.0001) (Fig.
7). These results provide compelling evidence that Bap plays an
important role in biofilm formation byA. baumannii ST92 strains
associated with hospital infection outbreaks.
DISCUSSION
A. baumannii strains from ST92 and the associated CC92 (also
known as European clone 2 or worldwide clone 2) represent the
most sampled and widespread A. baumannii sequence type across
the globe. Antibiotic susceptibility within ST92 is variable, sug-
gesting a role for mechanisms other than antibiotic resistance in
its successful dissemination. In this study, we examined the prev-
alence, sequence, and function of Bap from a collection of A. bau-
mannii ST92 strains isolated from a single institution over a 10-
year period.
Bap was first detected in S. aureus strains that cause bovine
mastitis (42). Subsequently, more Bap homologues have been
identified and characterized from a range of Gram-positive and
Gram-negative bacteria, including A. baumannii (13, 17–22,
FIG 3 Genome context of the bap gene in Acinetobacter. (A) Genomic analysis of different Acinetobacter species indicates that bap is located at the same
chromosomal position in all strains examined. The genome orientation was reversed for some strains to facilitate visualization (). Also indicated are the
respective core (black) and variable (green) regions flanking the bap gene. Orange triangles indicate the locations of sequence repeats. Genome alignments were
performed using Easyfig (25). (B) Alignment of palindromic repeats localized upstream and downstream of the bap gene in Acinetobacter. The axis is indicated
by a gray arrow.
FIG 4 Microtiter plate biofilm formation by MS2989 in comparison to
MS3640. Strains were grown under shaking conditions at 28°C for 24 h in
polyvinyl chloride (PVC) microtiter plates containing M9 supplemented with
0.3% Casamino Acids. Plates were washed to remove nonadherent cells and
stained with 0.01% crystal violet. Biofilm formation was quantified by solubi-
lizing the crystal violet stain retained by adherent cells with ethanol-acetone
(80:20) and measuring the absorbance at 595 nm. Results are the means for
eight replicates per strain (	 standard deviation). Mean values for MS3640
(0.4604) and MS2989 (0.7425) were calculated using GraphPad Prism 5 soft-
ware (P 0.001).
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43–51). Common features of Bap in all of these organisms include
its large size, the presence of multiple tandem repeats, its cell sur-
face location and its role in biofilm formation. In Pseudomonas
fluorescens, a large-repeat Bap-like protein referred to as LapA
contributes to surface attachment and biofilm formation (21).
LapA is translocated to the cell surface by an ABC transporter
encoded by the adjacent lapEBC genes (52). Similarly, in Salmo-
nella enterica serovar Enteritidis, BapA is secreted by a type I pro-
tein secretion system (BapBCD) situated downstream of the bapA
gene (46). Examination of the genetic location of bap in A. bau-
mannii did not reveal any evidence of a system that could mediate
its translocation. Thus, the mechanism by which Bap is trans-
ported to the surface of A. baumannii remains to be elucidated.
We note that a small but significant increase in biofilm formation
was observed in the recombinant E. coliMS2989 strain expressing
Bap, indicating that there may be some level of redundancy in its
mode of export. However, we were unable to definitively detect
Bap expression on the surface of E. coliMS2989 by immunofluo-
rescencemicroscopy, suggesting that the level of Bapwas very low.
Our analysis revealed that the bap gene is highly prevalent inA.
baumannii ST92 strains. All but one A. baumannii strain in our
collection (i.e., MS3007) also expressed the Bap protein. The in-
FIG 5 (A)Western blot obtained using Bap-specific antiserum showing expression of Bap (200 kDa) in A. baumanniiMS3009 (lane 3), MS3011 (lane 4), and
MS3014 (lane 5) but not MS3007 (lane 2) from whole-cell lysates of overnight shaking cultures. Molecular mass markers (HiMark prestained protein standard)
are indicated in lane 1. (B) Immunofluorescence microscopy demonstrating surface localization of Bap. Phase contrast (i) and fluorescence (ii) images of
MS3007, MS3009, MS3011, and MS3014 cells following overnight growth with agitation at 28°C are shown. Bar, 5 m.
FIG 6 Flow chamber biofilm formation byMS3007 (A), MS3009 (B), MS3011 (C), andMS3014 (D). Biofilm development wasmonitored by CLSM 48 h postinocu-
lation. Substratum coverage of each strain is as follows:MS3007, 29.96%;MS3009, 53.26%;MS3011, 60.7% andMS3014, 60.38% (P 0.002). Micrographs represent
horizontal sections. Depicted to the right of and below each panel are the yz plane and xz plane, respectively, at the positions indicated by the lines.
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consistencies between gene prevalence by PCR and protein ex-
pression are most likely due to sequence variation. It is possible
that MS3007 harbors an incomplete or truncated bap gene. In-
deed, Loehfelm et al. previously reported the presence of short
homologous regions of bapAB307-0294 within the genome sequence
of A. baylyi and A. baumannii ATCC 17978 (13).
The previously characterized A. baumannii BapAB307-0294 is a
high-molecular-mass (854-kDa) protein consisting of multiple
repeat regions (13). In contrast, the A. baumannii ST92 strains
examined in this study all expressed a Bap protein of approxi-
mately 200 kDa. A partial sequence of the bap gene was obtained
from one strain,MS1968, which represented the index case isolate
from a small outbreak in 2001. Given that the A. baumannii
MS1968 bap gene is 16 kb, we expected it to encode a signifi-
cantly larger protein. It is possible that Bap1968 is degraded or even
processed; however, this remains to be determined. The difference
in the size of the bap genes from A. baumannii strains MS1968
(16 kb) and AB307-0294 (25.863 kb), despite their similar ge-
netic context, also demonstrates that there is significant variation
in the bap genes from different A. baumannii strains. The A. bau-
mannii Bap protein contains a modular structure (53), and the
presence of large, identical repeat sequences within module D of
bapMS1968 prevented us from generating a complete sequence of
the gene. However, we did identify a nonrepetitive sequence that
was used to examine the phylogeny of Bap from several species. In
comparison to BapAB307-0294 (which clustered in CC1), BapMS1968
clustered in CC2. The two Bap sequences exhibited significant
variation and displayed only 37% amino acid identity over this
region. Further analysis of Bap from other CC1 and CC2 strains
was consistent with this clustering, and suggests that the nonre-
petitive sequence of Bap can differentiate between CC1 and CC2
strains. When analyzed in the context of Bap sequences from dif-
ferent organisms, all of the A. baumannii Bap homologues clus-
tered uniquely. It remains to be determined if this nonrepetitive
region of Bap is representative of its phylogenic distribution in
comparison to the entire protein sequence. However, given the
size and highly repetitive nature of Bap, this approach avoided the
comparative analysis of regions that might potentially contain
multiple sequence errors.
Several lines of evidence suggest that Bap contributes to bio-
film formation by A. baumannii ST92. First, Bap expression by
three A. baumannii strains was associated with strong biofilm
growth, while the A. baumannii ST92 strain MS3007, which did
not express Bap, did not form a biofilm in microtiter plate- and
flow cell-based assays. Additionally, affinity-purified Bap-specific
antibodies blocked Bap-mediated biofilm formation by A. bau-
mannii strains MS3009, MS3011, and MS3014. Taken together,
our results demonstrate a role for Bap in biofilm formation that is
consistent with previous literature examining other A. baumannii
strains (13, 16). Our results should provide the basis for more
detailed studies to examine the translocation and function of Bap
in A. baumannii, including other common multidrug-resistant
sequence types associated with hospital infection outbreaks.
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